Advertisement
Home »

Survival-Adjusted FEV1 and BMI Percentiles for Patients with Cystic Fibrosis before the Era of Triple CFTR Modulator Therapy in Germany.

Apr 17, 2023

ABOUT THE EXPERTS

  • A Susanne Dittrich

    Department of Pneumology and Critical Care Medicine, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany, Susanne.Dittrich@med.uni-heidelberg.de.

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany, Susanne.Dittrich@med.uni-heidelberg.de.

    Markus Dumke

    Stat-Up, Munich, Germany.

    Ferdinand Kapl

    Stat-Up, Munich, Germany.

    Philipp Schneider

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

    Sabine Wege

    Department of Pneumology and Critical Care Medicine, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany.

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

    Simon Gräber

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

    Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany.

    German Center for Lung Research (DZL), associated partner, Berlin, Germany.

    Mirjam Stahl

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

    Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany.

    German Center for Lung Research (DZL), associated partner, Berlin, Germany.

    Felix J Herth

    Department of Pneumology and Critical Care Medicine, Thoraxklinik at the University Hospital Heidelberg, Heidelberg, Germany.

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

    Lutz Naehrlich

    Department of Pediatrics, Justus-Liebig-University, Giessen, Germany.

    Mukoviszidose Institut gGmbH (MI), Bonn, Germany.

    Marcus A Mall

    Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

    Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Berlin, Germany.

    German Center for Lung Research (DZL), associated partner, Berlin, Germany.

    Olaf Sommburg

    Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

    Division of Pediatric Pulmonology & Allergy and Cystic Fibrosis Center, Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement